QT Medical

QT Medical has developed a novel, FDA-cleared platform for 12-lead resting ECGs that dramatically simplifies the traditional process. Its system, centered on the disposable QHeart® sensor and the PCA 500® recorder, reduces setup time and operator error, enabling reliable ECG capture in non-traditional settings like the home. With regulatory clearances in the US (FDA), EU (CE Mark), Canada, and Thailand, and certifications including ISO 13485 and ISO 27001, the company is positioned to capitalize on the growing demand for decentralized cardiac monitoring and telemedicine solutions. Recent participation in the Mayo Clinic & ASU MedTech Accelerator underscores its clinical and strategic momentum.

Integrated hardware/software platform for simplified 12-lead ECG capture. Core components: single-use QHeart® sensor patch (replaces 10 wires), PCA 500® mobile recorder, QT ECG mobile app, and HIPAA-compliant ECGcloud® for data management.

QT Medical competes in the ECG device market against large, established players like GE Healthcare, Philips, and Hillrom, which offer traditional and some wireless systems. It also competes with newer digital health companies focusing on patch-based or handheld ECG monitors (e.g., for single-lead or reduced-lead monitoring). QT Medical's differentiation is its focus on making the full, diagnostic-standard 12-lead ECG simple and accessible without sacrificing clinical accuracy.